Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
7.95
+0.14 (1.79%)
Nov 4, 2024, 4:00 PM EST - Market closed

Sera Prognostics Revenue

Sera Prognostics had revenue of $24.00K in the quarter ending June 30, 2024, a decrease of -80.49%. This brings the company's revenue in the last twelve months to $107.00K, down -71.47% year-over-year. In the year 2023, Sera Prognostics had annual revenue of $306.00K with 14.18% growth.

Revenue (ttm)
$107.00K
Revenue Growth
-71.47%
P/S Ratio
n/a
Revenue / Employee
$1,877
Employees
57
Market Cap
265.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023306.00K38.00K14.18%
Dec 31, 2022268.00K186.00K226.83%
Dec 31, 202182.00K57.00K228.00%
Dec 31, 202025.00K-11.00K-30.56%
Dec 31, 201936.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
Amarin Corporation 241.02M
Zynex 193.67M
Heron Therapeutics 136.36M
Poseida Therapeutics 88.46M
Artiva Biotherapeutics 29.26M
TScan Therapeutics 12.20M
Immutep 2.56M
Revenue Rankings